RayStation is making its way to Japan for the first time
January 18, 2018 – RayStation has been chosen as the treatment planning system for a new carbon-ion therapy facility which is under construction at Yamagata University Hospital in northern Japan. The order represents the first RayStation carbon ion installation in Japan.
RayStation was selected jointly by Yamagata University Hospital and Toshiba, which is supplying the treatment delivery system. The decision was motivated by RayStation’s outstanding functionality and comprehensive support for this cutting-edge treatment technique. The RayStation installation will include modules for carbon pencil beam scanning with robust biological optimization (using both the MKM and LEM models), deformable registration, dose tracking and adaptive therapy.
The facility expects to treat its first patients by early 2020. Toshiba’s treatment delivery system will comprise two treatment rooms, a fixed-port room and a 360-degree rotating compact superconducting gantry. The facility will be the most compact carbon ion installation in the world, and one of the few integrated into a general hospital.
For more information :
https://www.itnonline.com/content/raystation-selected-new-carbon-ion-therapy-center-japan
🆔 @partohair
January 18, 2018 – RayStation has been chosen as the treatment planning system for a new carbon-ion therapy facility which is under construction at Yamagata University Hospital in northern Japan. The order represents the first RayStation carbon ion installation in Japan.
RayStation was selected jointly by Yamagata University Hospital and Toshiba, which is supplying the treatment delivery system. The decision was motivated by RayStation’s outstanding functionality and comprehensive support for this cutting-edge treatment technique. The RayStation installation will include modules for carbon pencil beam scanning with robust biological optimization (using both the MKM and LEM models), deformable registration, dose tracking and adaptive therapy.
The facility expects to treat its first patients by early 2020. Toshiba’s treatment delivery system will comprise two treatment rooms, a fixed-port room and a 360-degree rotating compact superconducting gantry. The facility will be the most compact carbon ion installation in the world, and one of the few integrated into a general hospital.
For more information :
https://www.itnonline.com/content/raystation-selected-new-carbon-ion-therapy-center-japan
🆔 @partohair
Imaging Technology News
RayStation Selected for New Carbon Ion Therapy Center in Japan
January 18, 2018 – RayStation has been chosen as the treatment planning system for a new carbon-ion therapy facility which is under construction at Yamagata University Hospital in northern Japan. The order represents the first RayStation carbon ion installation…
♦️ثبت نام کنکور ۹۷
مشاور عالی سازمان سنجش آموزش کشور گفت: ثبت نام برای شرکت در آزمون سراسری سال ۹۷ از اول بهمن آغاز می شود و تا هشتم بهمن ادامه دارد.
🆔: @partohair
مشاور عالی سازمان سنجش آموزش کشور گفت: ثبت نام برای شرکت در آزمون سراسری سال ۹۷ از اول بهمن آغاز می شود و تا هشتم بهمن ادامه دارد.
🆔: @partohair
میلاد مظهر صبر و شکیبایی حضرت زینب (س) و روز پرستار مبارک باد
ID:@partohair
ID:@partohair
First Hospitals Achieve Inter-System Connectivity Across Accuray Radiation Therapy Platforms
More information 👇
🆔 @partohair
More information 👇
🆔 @partohair
iDMS Data Management System helps improve treatment outcomes and efficiency by sharing patient data throughout the entire disease management period
January 19, 2018 — Accuray Inc. announced recently that the Heidelberg University Hospital in Heidelberg, Germany, and Oscar Lambret Cancer Center in Lille, France, are the first in the world to connect both their Accuray CyberKnife and TomoTherapy platforms to the iDMS Data Management System. The two facilities are now able to benefit from a centralized database that shares and makes data accessible across the radiation therapy treatment delivery platforms, adding flexibility and improving efficiency in their radiation therapy departments.
The iDMS System allows for the seamless integration of a wide range of technologies including the Radixact, TomoTherapy and CyberKnife Systems, Accuray Precision Treatment Planning System (TPS), and third-party treatment planning and oncology information systems (OIS). As a result, clinicians can leverage the technology and data they need to optimize each patient treatment.
Radiotherapy is a key component of our multidisciplinary approach to treating cancer. With the installation of the iDMS Data Management System we have the flexibility to treat patients using either our TomoTherapy Systems or our new CyberKnife M6 System, while maintaining one patient record. This simplifies and speeds up the entire treatment process, while enabling us to adapt how we choose to deliver the radiation treatment at each session based on the needs of the patient," said Xavier Mirabel, M.D., head of the Department of Radiation Oncology and Brachytherapy, Oscar Lambret Cancer Center.
For more information :
https://www.itnonline.com/content/first-hospitals-achieve-inter-system-connectivity-across-accuray-radiation-therapy-platforms
🆔 @partohair
January 19, 2018 — Accuray Inc. announced recently that the Heidelberg University Hospital in Heidelberg, Germany, and Oscar Lambret Cancer Center in Lille, France, are the first in the world to connect both their Accuray CyberKnife and TomoTherapy platforms to the iDMS Data Management System. The two facilities are now able to benefit from a centralized database that shares and makes data accessible across the radiation therapy treatment delivery platforms, adding flexibility and improving efficiency in their radiation therapy departments.
The iDMS System allows for the seamless integration of a wide range of technologies including the Radixact, TomoTherapy and CyberKnife Systems, Accuray Precision Treatment Planning System (TPS), and third-party treatment planning and oncology information systems (OIS). As a result, clinicians can leverage the technology and data they need to optimize each patient treatment.
Radiotherapy is a key component of our multidisciplinary approach to treating cancer. With the installation of the iDMS Data Management System we have the flexibility to treat patients using either our TomoTherapy Systems or our new CyberKnife M6 System, while maintaining one patient record. This simplifies and speeds up the entire treatment process, while enabling us to adapt how we choose to deliver the radiation treatment at each session based on the needs of the patient," said Xavier Mirabel, M.D., head of the Department of Radiation Oncology and Brachytherapy, Oscar Lambret Cancer Center.
For more information :
https://www.itnonline.com/content/first-hospitals-achieve-inter-system-connectivity-across-accuray-radiation-therapy-platforms
🆔 @partohair
Imaging Technology News
First Hospitals Achieve Inter-System Connectivity Across Accuray Radiation Therapy Platforms
Accuray Inc. announced recently that the Heidelberg University Hospital in Heidelberg, Germany, and Oscar Lambret Cancer Center in Lille, France, are the first in the world to connect both their Accuray CyberKnife and TomoTherapy platforms to the iDMS Data…
cosmic ray neutron sensing.pdf
4.6 MB
Cosmic ray neutron sensing:Use, calibration and validation for soil moisture estimation
🆔 @partohair
🆔 @partohair
FFF Accelerators.pdf
520.3 KB
Flattening filter-free accelerators: a report from the AAPM therapy emerging technology assessment work group
🆔 @partohair
🆔 @partohair
A novel positron emission tomography/magnetic resonance imaging (PET/MRI) test can determine whether a kidney transplant patient has developed infection in the transplanted tissue, according to a new study.
Researchers at Hannover Medical School (Germany) conducted a study involving 13 kidney transplant recipients with complicated urinary tract infections (UTIs) in order to determine whether molecularly targeted PET/MRI could enable the detection of leukocytes in renal allografts. The patients underwent both PET with a specific CXCR4 ligand (68Ga-pentixafor), and diffusion-weighted MRI. The spatial distribution and intensity of CXCR4 upregulation in the kidney transplants were analyzed and compared with urinalysis, clinical chemistry and bacteriology, and biopsy (if available).
For more information:
Nuclear Medicine Test Identifies Kidney Transplant Infection - Nuclear Medicine - mobile.Medimaging.net
https://mobile.medimaging.net/nuclear-medicine/articles/294771651/nuclear-medicine-test-identifies-kidney-transplant-infection.html
🆔@partohair
Researchers at Hannover Medical School (Germany) conducted a study involving 13 kidney transplant recipients with complicated urinary tract infections (UTIs) in order to determine whether molecularly targeted PET/MRI could enable the detection of leukocytes in renal allografts. The patients underwent both PET with a specific CXCR4 ligand (68Ga-pentixafor), and diffusion-weighted MRI. The spatial distribution and intensity of CXCR4 upregulation in the kidney transplants were analyzed and compared with urinalysis, clinical chemistry and bacteriology, and biopsy (if available).
For more information:
Nuclear Medicine Test Identifies Kidney Transplant Infection - Nuclear Medicine - mobile.Medimaging.net
https://mobile.medimaging.net/nuclear-medicine/articles/294771651/nuclear-medicine-test-identifies-kidney-transplant-infection.html
🆔@partohair
MedImaging.net
Nuclear Medicine Test Identifies Kidney Transplant Infection
A novel positron emission tomography/magnetic resonance imaging (PET/MRI) test can determine whether a kidney transplant patient has developed infection in the transplanted tissue, according to a new study.